Intersect Ent Inc
NASDAQ:XENT
Intersect Ent Inc
NASDAQ:XENT
Price:
28.24 USD
Market Closed
Updated:
May 3, 2024
Section:
Relative Value
There is not enough data to reliably calculate the relative value of XENT.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
XENT
Relative Value
Base Case
Not Available
Valuation Multiples
Multiples Across Competitors
XENT Competitors Multiples
Intersect Ent Inc Competitors
Intersect Ent Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Intersect Ent Inc
NASDAQ:XENT
|
954.8m USD | 9.2 | -5.7 | -14.1 | -13.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.7B USD | 4.6 | 32.6 | 19.2 | 28.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
134B USD | 18.3 | 67.4 | 55.3 | 69.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
124.3B USD | 5.9 | 37 | 24 | 29.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
107.6B USD | 3.3 | 25.6 | 13.6 | 19.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
105.6B USD | 7.2 | 59.8 | 30.5 | 45 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
69.4B USD | 3.6 | 57 | 19 | 40.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
57.6B EUR | 2.6 | 38 | 18.3 | 30.8 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.2B USD | 8.3 | 36.2 | 26.3 | 28.5 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | 32.5 | 28.3 | 28.3 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.2B USD | 13.2 | 78.5 | 58.6 | 76.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
